Latest news
Publications
Evonetix appoints Dr Michael Daniels as Head of Product Management
Evonetix, the synthetic biology company developing a desktop platform for scalable,...
Evonetix named Biotech Scale-up of the Year at 2020 Business Weekly Awards
Evonetix, the Cambridge-based company pioneering an innovative approach to scalable and...
Evonetix and Analog Devices Collaborate on Third-Generation DNA Synthesis Platform
Evonetix, the Cambridge-based company pioneering an innovative approach to scalable and...
Evonetix raises $30 million USD (£23 million GBP)
PRESS RELEASE 02 March 2020 Evonetix raises $30 million USD (£23 million GBP) Series B...
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform
Evonetix, the Cambridge-based company pioneering an innovative approach to scalable and...
Evonetix expands facilities and relocates to central Cambridge, UK
Evonetix, the Cambridge-based company pioneering an innovative approach to scalable and...
Publications
International Biopharmaceutical Industry
December, 2020 - Transforming the Healthcare landscape with synthetic biology and living medicines. This article has been published in Volume 3 Issue 3 of the IBI...
Innovations in Pharmaceutical Technology
November, 2020 - Putting DNA Synthesis in the Hands of Every Researcher. This article is taken from Innovations in Pharmaceutical Technology Autumn/Winter 2020, pages 22-25. © Samedan...
Chemistry Today
September, 2020 - Unlocking synthetic biology through DNA synthesis. Chemistry Today article by Stuart Crosby, Head of Synthetic Chemistry at...
Careers in Discovery
July, 2020 - Careers in Discovery podcast with Tim Brears, CEO of Evonetix